Myeloma and Related Diseases Registry (MRDR)

The MRDR has reached 4,000 patients registered!!! - an incredible achievement that wouldn't be possible without the support, commitment and great work of participants, site staff and collaborators. Thank you to everyone who has helped make this happen - we look forward to sharing many more milestones with you.

Find out more

This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.

What is the registry?

Learn about how the registry works and the data we collect.
Benefits

Participation in the registry provides advantages for sites and patients.
About our projects

Find out about MRDR projects and how registry data is being used.
4079

Patients accrued

2698

Patients with multiple myeloma

50

Number of approved sites

471

Biobank participants

Latest news

4000 participants!!!
02 Oct 2020

The MRDR has reached 4000 patients registered!

Read more
MRDR webinar at National Myeloma Workshop: 5 Sept
10 Aug 2020

We invite you to the free MRDR webinar: 5 Sept, 4-5pm

Read more
My-PROMPT trial published!
05 Apr 2020

Real-time feedback of patient-reported outcomes feasible for patients and clinicians!

Read more
COVID-19 NOTICE
20 Mar 2020

MRDR still operating during COVID-19 pandemic.

Read more

Participating organisations